| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.44 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.33 | 2e-11 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.32 | 8e-11 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.31 | 0.02 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.25 | 2e-05 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.23 | 5e-09 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.23 | 0.0002 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.07 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-07 |